Xylem Inc. (NYSE:XYL) Stock Has Consensus Target Price of $140.85

Shares of Xylem Inc. (NYSE:XYL – Get Free Report) have been given an average rating of “Moderate Buy” by the eighteen research firms that are currently covering the stock, MarketBeat reports. Eight analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $122.31.

A number of brokerages have recently weighed in on XYL. Citigroup cut their target price on Xylem from $148.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday. Royal Bank Of Canada decreased their price target on Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a research report on Wednesday. The Goldman Sachs Group decreased their price target on Xylem from $160.00 to $138.00 and set a “buy” rating for the company in a research report on Wednesday. Weiss Ratings reiterated a “hold (c)” rating on shares of Xylem in a report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. cut Xylem from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $118.00 to $90.00 in a research report on Wednesday.

Get Our Latest Stock Report on Xylem

Xylem Stock Down 4.9%

XYL opened at $88.31 on Monday. Xylem has a fifty-two week low of $87.40 and a fifty-two week high of $154.27. The firm has a market capitalization of $20.62 billion, a P/E ratio of 21.03, a PEG ratio of 1.75 and a beta of 1.00. The company’s 50-day moving average is $105.98 and its 200 day moving average is $118.05. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24.

Xylem (NYSE:XYL – Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). The firm had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.37 earnings per share. Research analysts expect that Xylem will post 5.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.9%. Xylem’s dividend payout ratio (DPR) is currently 40.95%.

Hedge Funds Weigh In On Xylem

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in Xylem during the 2nd quarter valued at $2,959,730,000. State Street Corp lifted its position in shares of Xylem by 2.4% during the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock worth $1,352,874,000 after acquiring an additional 270,972 shares in the last quarter. XXEC Inc. bought a new position in shares of Xylem in the second quarter worth $850,841,000. Swedbank AB boosted its holdings in shares of Xylem by 0.3% in the first quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock worth $660,444,000 after acquiring an additional 18,759 shares during the period. Finally, Royal Bank of Canada boosted its holdings in shares of Xylem by 1.1% in the first quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company’s stock worth $569,207,000 after acquiring an additional 53,210 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Xylem

Here are the key news stories impacting Xylem this week:

  • Positive Sentiment: Despite the near-term concerns, Xylem reported adjusted earnings of $1.44 per share, up from $1.37 a year earlier, while orders increased approximately 10%. Several firms still see substantial longer-term upside: Citigroup maintained a “buy” rating with a $130 target, BNP Paribas Exane retained “outperform” at $135, and Oppenheimer kept “outperform” at $135. Citigroup analyst action
  • Neutral Sentiment: Xylem plans portfolio divestitures and a segment restructuring, which could improve focus and efficiency over time but may create execution costs and disruption in the near term. Xylem restructuring article
  • Negative Sentiment: Third-quarter revenue was $2.20 billion, about $80 million below expectations and down 3% year over year; adjusted EPS also narrowly missed consensus. Weakness in metering and project timing contributed to the shortfall. Xylem Q3 revenue miss
  • Negative Sentiment: Management lowered its 2026 revenue and profit outlook and issued cautious fourth-quarter expectations, citing customer pullbacks and ongoing operational headwinds. The guidance cut prompted multiple target reductions, including RBC to $125, Stifel to $114, and JPMorgan to $90; JPMorgan also downgraded the stock to “underweight.” Xylem outlook reduction
  • Negative Sentiment: Put-option purchases were unusually heavy, rising roughly 358% above average daily volume, signaling increased hedging or bearish speculation. In addition, Levi & Korsinsky announced an investigation into potential securities-law violations related to shareholder losses. Xylem investigation notice

About Xylem

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

Featured Stories

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.